Plain-English translation of NCT07320872 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some people develop psoriasis by studying a protein called vaspin and its genetic variations. This study will compare vaspin levels in people diagnosed with psoriasis and healthy volunteers to see if differences in this protein might explain why the disease develops. Understanding this connection could help doctors better predict who is at risk and improve treatment options.
Psoriasis is a lifelong skin disease that affects millions of people, but doctors still don't fully understand what causes it. Recent research suggests that certain proteins produced by body fat tissue, like vaspin, may play a role in triggering psoriasis. This study exists to explore that connection and fill gaps in our understanding of how the disease develops.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have a blood sample drawn to measure vaspin protein levels and analyze your genes related to vaspin. Researchers will also assess how severe your psoriasis is using a standard scoring system. The study compares 30 people with psoriasis to 30 healthy volunteers, so the main commitment is a single visit for blood work and assessment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt
Enrollment target
~60 participants
Started
August 2025
Primary completion
August 2026
Age range
18 Years – 50 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ola Mahmoud Samy Mohamed, MSC
Dermatology, Venereology and Andrology.Faculty of Medicine, Aswan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.